Insulet (PODD) Price to Sales (2010 - 2026)

Insulet (PODD) has reported Price to Sales for 17 consecutive years, with 13.17 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 61.34% year-over-year to 13.17; the trailing twelve-month figure through Jun 2026 stood at 3.46 (down 63.11% YoY), and the FY2025 full-year result was 7.39, down 16.48% from the prior year.
• Price to Sales fell to 13.17 in Q2 2026 per PODD's latest filing, from 19.08 in the prior quarter.
• Across five years, Price to Sales topped out at 62.51 in Q1 2022 and bottomed at 13.17 in Q2 2026.
• Historically, Price to Sales has averaged 36.41 across 5 years, with a median of 30.71 in 2024.
• The sharpest annual moves came in 2025 and 2026: Price to Sales gained 19.52% in 2025, then tumbled 61.34% in 2026.
• Over 5 years, Price to Sales stood at 55.35 in 2022, then plunged by 46.25% to 29.75 in 2023, then gained by 3.08% to 30.67 in 2024, then fell by 16.77% to 25.53 in 2025, then slumped by 48.4% to 13.17 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 13.17, 19.08, and 25.53 for Q2 2026, Q1 2026, and Q4 2025 respectively.